Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CLOROX CO /DE/ Director's Dealing 2020

May 15, 2020

30403_dirs_2020-05-15_08450418-3a24-4e64-8bba-ab5afcdb677f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CLOROX CO /DE/ (CLX)
CIK: 0000021076
Period of Report: 2020-05-13

Reporting Person: Jacobsen Kevin B (EVP - Chief Financial Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-05-13 Common Stock M 15630.0000 $89.8200 Acquired 21452.0000 Direct
2020-05-13 Common Stock M 3585.0000 $84.4500 Acquired 25037.0000 Direct
2020-05-13 Common Stock S 3563.0000 $205.4880 Disposed 21474.0000 Direct
2020-05-13 Common Stock S 5419.0000 $206.5359 Disposed 16055.0000 Direct
2020-05-13 Common Stock S 6084.0000 $207.2839 Disposed 9971.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-05-13 Stock Option (Right to Buy) $84.4500 M 3585.0000 Disposed 2023-09-17 Common Stock (3585.0000) Direct
2020-05-13 Stock Option (Right to Buy) $89.8200 M 15630.0000 Disposed 2024-09-17 Common Stock (15630.0000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 40.0000 Indirect
Common Stock 24.0000 Indirect
Common Stock 3145.0000 Indirect

Footnotes

F1: Transaction executed pursuant to a pre-planned trading program adopted by reporting person on February 13, 2020, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934. All transactions subject to the pre-planned program have been executed.

F2: This transaction was executed in multiple trades at prices ranging from $204.91 to $205.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F3: This transaction was executed in multiple trades at prices ranging from $205.94 to $206.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $206.95 to $207.90. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: Includes 84 shares acquired pursuant to a dividend reinvestment feature of the Company's Stock Incentive Plan.

F6: Includes 19 shares acquired through dividend reinvestment during the fiscal year.